Skip to content

Alert a, Hdl-Apoliporotein a, Test Kit

by Hyland Therapeutic Div., Travenol Laboratories

510(k) K802610

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 6 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 6 Oct 2026. What this means

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK802610 Date5 Jan 1981ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 6 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
DER
Device Class
Class II
Regulation
21 CFR Part 866.5580
Advisory Committee
Immunology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Alert A HDL-Apolipoprotein A Test Kit is an in vitro diagnostic device classified as an Alpha-1-Lipoprotein Antigen, Antiserum, and Control set. It is designed for the qualitative detection of HDL-apolipoprotein A in human serum or plasma, aiding in the assessment of high-density lipoprotein metabolism and cardiovascular risk evaluation.

This test kit is intended for laboratory use only and is supplied as a single-use diagnostic reagent. It requires no special storage conditions beyond refrigeration and is regulated under FDA 510(k) clearance (K802610) as a Class II device. The kit includes necessary reagents and controls for accurate testing, adhering to immunology-based diagnostic standards.

Other devices from Hyland Therapeutic Div., Travenol Laboratories

See all devices from Hyland Therapeutic Div., Travenol Laboratories →

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What clinical purpose does the Alert A HDL-Apolipoprotein A Test Kit serve in patient assessment?

    The Alert A HDL-Apolipoprotein A Test Kit is used to qualitatively detect HDL-apolipoprotein A in human serum or plasma. This helps laboratories assess high-density lipoprotein (HDL) metabolism, which is relevant for evaluating a patient’s cardiovascular risk. It supports diagnostic workflows in immunology-based testing environments.

  • Is this test kit designed for single-use or repeated testing, and how should it be stored?

    The Alert A HDL-Apolipoprotein A Test Kit is explicitly designed for single-use only as a diagnostic reagent. It requires standard refrigeration for storage—no additional conditions are specified—so it remains stable until use. Always check the expiration date before use.

  • What regulatory pathway was followed for FDA clearance of this device, and what class does it belong to?

    The Alert A HDL-Apolipoprotein A Test Kit was cleared through the traditional 510(k) pathway under FDA’s Class II designation (K802610). It was reviewed by the Immunology (IM) Advisory Committee and determined to be substantially equivalent to a predicate device, adhering to FDA’s immunology-based diagnostic standards.

  • Can this test kit be used outside a laboratory setting, or is it strictly for professional use?

    The Alert A HDL-Apolipoprotein A Test Kit is intended for laboratory use only. It is not designed for point-of-care or home testing, as it requires controlled diagnostic environments and specialized handling of reagents and controls.